Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

PRTAV

Prothena Corp. Plc - Ordinary Shares (MM) (PRTAV)

Prothena Corp. Plc - Ordinary Shares (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PRTAV
日付受信時刻ニュースソース見出しコード企業名
2022/10/2805 : 05GlobeNewswire Inc.Prothena to Report Third Quarter 2022 Financial Results on November 3rdNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/09/0205 : 20GlobeNewswire Inc.Prothena to Participate in Upcoming Healthcare ConferencesNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/09/0205 : 05GlobeNewswire Inc.Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of DirectorsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/08/0905 : 05GlobeNewswire Inc.Prothena Reports Second Quarter 2022 Financial Results and Business HighlightsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/08/0305 : 05GlobeNewswire Inc.Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/08/0205 : 05GlobeNewswire Inc.Prothena to Report Second Quarter 2022 Financial Results on August 8thNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/07/0205 : 16GlobeNewswire Inc.Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/06/0305 : 05GlobeNewswire Inc.Prothena to Participate in Jefferies Healthcare ConferenceNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/05/0605 : 05GlobeNewswire Inc.Prothena Reports First Quarter 2022 Financial Results and Business HighlightsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/04/2905 : 05GlobeNewswire Inc.Prothena to Report First Quarter 2022 Financial Results on May 5thNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/04/2621 : 30GlobeNewswire Inc.Prothena Receives FDA Fast Track Designation for PRX012, a Next-Generation Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s DiseaseNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/03/2821 : 30GlobeNewswire Inc.Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s DiseaseNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/03/2205 : 05GlobeNewswire Inc.Prothena to Participate in Stifel 2022 Virtual CNS DaysNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/03/1618 : 30GlobeNewswire Inc.Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/02/1806 : 05GlobeNewswire Inc.Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business HighlightsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2022/02/1106 : 05GlobeNewswire Inc.Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/11/3006 : 05GlobeNewswire Inc.Prothena to Participate in JMP Securities Hematology and Oncology SummitNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/11/0505 : 05GlobeNewswire Inc.Prothena Reports Third Quarter 2021 Financial Results and Business HighlightsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/10/2905 : 05GlobeNewswire Inc.Prothena to Report Third Quarter 2021 Financial Results on November 4thNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/10/0205 : 30GlobeNewswire Inc.Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/10/0205 : 05GlobeNewswire Inc.Prothena Announces Executive AppointmentsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/09/0405 : 05GlobeNewswire Inc.Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/09/0205 : 05GlobeNewswire Inc.Prothena to Participate in Upcoming September Healthcare ConferencesNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/08/0605 : 05GlobeNewswire Inc.Prothena Reports Second Quarter 2021 Financial Results and Business HighlightsNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/07/3005 : 05GlobeNewswire Inc.Prothena to Report Second Quarter 2021 Financial Results on August 5thNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/07/2622 : 00GlobeNewswire Inc.Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association International Conference 2021NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/07/2105 : 05GlobeNewswire Inc.Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association International Confer...NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/07/1220 : 00GlobeNewswire Inc.Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis ProgrammeNASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/06/2421 : 30GlobeNewswire Inc.Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global Neuroscience Research and ...NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
2021/06/1103 : 18GlobeNewswire Inc.Prothena to Participate in JMP Securities Life Sciences Conference on June 16NASDAQ:PRTAVProthena Corp. Plc - Ordinary Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:PRTAV